A Way Forward for Cancer Chemoprevention: Think Local

Area of Science:

• Oncology
• Cancer Prevention Research
• Pharmacology

Background:

• Carcinogenesis involves extensive genetic and molecular changes, leading to tumor heterogeneity and reduced therapeutic success.
• Early-stage cancer chemoprevention within the primary organ offers greater therapeutic efficacy due to a lower molecular aberration burden.
• Systemic toxicity is a significant barrier to widespread chemoprevention, often emerging with large-scale patient treatment.

Purpose of the Study:

• To review the rationale for localized therapeutic delivery in cancer chemoprevention.
• To highlight successful clinical applications of organ-specific chemoprevention strategies.
• To discuss ongoing research aimed at expanding the impact of localized cancer prevention.

Main Methods:

• Review of scientific literature and clinical data on localized cancer chemoprevention.
• Analysis of strategies focusing on therapeutic intervention within a single, at-risk organ.
• Evaluation of approaches designed to avoid systemic drug delivery and associated toxicities.

Main Results:

• Localized delivery of therapeutics to at-risk organs can achieve significant therapeutic efficacy.
• This strategy effectively bypasses the systemic toxicity concerns associated with traditional chemoprevention.
• Numerous clinical successes and ongoing research demonstrate the high impact of this localized approach.

Conclusions:

• Localized organ-specific therapeutic delivery is a rational and effective strategy for cancer chemoprevention.
• This approach overcomes the critical barrier of systemic toxicity, enabling wider application.
• The localized strategy holds substantial potential for future advancements in cancer prevention and treatment.